We provide you with 20 years of free, institutional-grade data for MTEM stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of MTEM. Explore the full financial landscape of MTEM stock.
| Reported Date | CIK | Ticker | Type |
|---|
Molecular Templates, Inc(NASDAQ:MTEM) 
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other diseases. Its proprietary drug platform technology is engineered toxin bodies (ETBs). The company's lead drug candidate is MT...
Website: http://www.mtem.com
Founded: 2000
Full Time Employees: 228
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about MTEM stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.